Search clinical trials for: docetaxel and epirubicin plus endostatin

Total 6120 results

Oregon Health and Science University

Active, not recruiting

Ghrelin Suppression by Octreotide in Prader-Willi

Prader Willis Syndrome
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Liver Cancer

United States
Novartis

Completed

Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide

Irritable Bowel Syndrome (IBS)

United Kingdom, United States, Canada, Sweden
Federico II University

Completed

Prediction of Tumor Shrinkage in Acromegaly

Acromegaly

Italy
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd

Unknown

Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel

Breast Cancer

China
Technical University of Munich

Unknown

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Breast Cancer

Germany
Shanghai General Hospital, Shanghai Jiao Tong University...

Unknown

Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric Cancer

Gastric Cancer

China
IRCCS Istituto delle Scienze Neurologiche di Bologna
Azienda Ospedaliera Città della Salute e della Scienza di Torino

Recruiting

DBS and Levodopa for Treating Freezing of Gait in Parkinson's Disease

Parkinson Disease | Freezing of Gait

Italy
Fudan University

Recruiting

mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer (PTCA199-7)

Pancreatic Adenocarcinoma

China
Tang-Du Hospital
Zhejiang University; Chipscreen Biosciences, Ltd.; First Affiliated Hospital...

Unknown

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Chronic HIV Infections

China
Beijing 302 Hospital

Unknown

Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure

Liver Failure | Mesenchymal Stem Cells

China
University of Michigan Rogel Cancer Center
Sanofi

Terminated

Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

Prostate Cancer

United States
Samyang Biopharmaceuticals Corporation

Completed

A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies

Advanced Solid Malignancies

Korea, Republic of
National Guard Health Affairs

Suspended

Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer (TAXIS01)

Non-small Cell Lung Cancer Metastatic

Saudi Arabia
Samsung Medical Center

Unknown

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Nasopharyngeal Cancer

Korea, Republic of
Uppsala University
Sahlgrenska University Hospital, Sweden; University Hospital, Umeå; Uppsala University... and other collaborators

Not yet recruiting

The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer (Lead4Care)

Prostate Cancer

Sweden
Sun Yat-sen University
Hunan Cancer Hospital; Beijing Biostar Pharmaceuticals Co., Ltd.

Recruiting

Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Rhone-Poulenc Rorer

Completed

Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Roswell Park Cancer Institute

Terminated

Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Gastric Cancer

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Sanofi

Completed

NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)

Head and Neck Neoplasms

Tunisia, Morocco, Algeria
Nordic Society of Gynaecological Oncology - Clinical...
European Organisation for Research and Treatment of Cancer - EORTC

Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Endometrial Cancer

France, Norway, Belgium, Spain, Netherlands, Italy, United Kingdom, Ireland, Poland, Portugal, South Africa
University of Wisconsin, Madison

Completed

Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

United States
Asan Medical Center
Seoul National University Bundang Hospital; Severance Hospital; Hallym University... and other collaborators

Recruiting

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH

Gastric Cancer, Adjuvant Chemotherapy, XO

Korea, Republic of
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

Breast Cancer | Neoadjuvant Chemotherapy

China
European Lung Cancer Working Party

Completed

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Malignant Mesothelioma

Belgium, France
Sun Yat-sen University
Peking University; Zhejiang Cancer Hospital; Xiangya Hospital of Central South... and other collaborators

Not yet recruiting

Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC (NX-NPC)

Nasopharyngeal Carcinoma

China
China National Center for Cardiovascular Diseases

Not yet recruiting

Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals With Obesity and NAFLD (BRAVO)

Obesity | NAFLD | Obesity, Abdominal

China
Beijing 302 Hospital

Completed

Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis

Liver Cirrhosis

China
Hoffmann-La Roche
Norwegian Radium Hospital

Completed

A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

Breast Cancer

Norway
Johns Hopkins University

Withdrawn

Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia

Aphasia

United States
Samsung Medical Center

Completed

Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment

Advanced Gastric Adenocarcinoma

Korea, Republic of
Incyte Corporation

Terminated

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

NSCLC (Non-small Cell Lung Carcinoma)

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Aichi Cancer Center

Completed

Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

Head and Neck Cancer

Japan
Seagen Inc.

Completed

FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma

Non-Small Cell Lung Carcinoma

United States
Sanofi

Completed

Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer

Cancer

United States, France, Canada, Russian Federation, Portugal, Argentina
GlaxoSmithKline

Completed

SB-715992 In Combination With Docetaxel In Patients With Solid Tumors

Solid Tumor Cancer

United Kingdom
Carilion Clinic
Sanofi

Terminated

A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation

Advanced Endometrial Adenocarcinoma, Stage III A, B, C

United States
Kyunghee University Medical Center

Unknown

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Solid Tumor
Sanofi

Completed

Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax

Lung Neoplasms

Turkey
Second Affiliated Hospital of Soochow University

Recruiting

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Advanced Solid Tumor | Refractory Tumor

China
Novartis

Completed

Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity

Obesity | Primary Insulin Hypersecretion

United States
Beijing 302 Hospital

Unknown

Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

China
Case Comprehensive Cancer Center

Completed

Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer

Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7

United States
Shanghai JMT-Bio Inc.

Not yet recruiting

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

Squamous Cell Non-small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel

Advanced Solid Tumors

China
NCIC Clinical Trials Group

Completed

OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

Canada

3

Subscribe